Accéder au contenu
Merck

[The Amben correction of disorders in the intestinal microbial colonization of newborn infants with perinatal pathology].

Zhurnal mikrobiologii, epidemiologii, i immunobiologii (1998-04-09)
M N Iakushenko, Zh A Tkhagapsoeva, V M Bondarenko
RÉSUMÉ

The examination of 49 newborn infants revealed that at the early neonatal period the character of the microbial colonization of the intestine depended on the kind of perinatal pathology: in lesions of the central nervous system and conjugation jaundice the deficiency of Bifidobacterium and Escherichia was detected; in hemolytic disease opportunistic bacteria were dominant simultaneously with the deficiency of lactoflora. The study of these infants, divided into two groups differing in the administration of Amben (an inhibitor of proteolytic enzymes), showed the efficiency of Amben which stimulated the growth and development of resident microflora in the intestine, thus contributing to the maintenance of eubiosis in a given group of infants with perinatal pathology.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
4-(Aminomethyl)benzoic acid, 97%